Lv A - Search Results

1

Application evaluation of clinical practice guidelines for traditional Chinese medicine: a clinical analysis based on the analytic hierarchy process.

Cai H, Li H, Zeng H, Xu D, Ouyang W, Lv A. Cai H, et al. Among authors: lv a. BMC Complement Altern Med. 2019 Oct 22;19(1):277. doi: 10.1186/s12906-019-2683-5. BMC Complement Altern Med. 2019. PMID: 31640688 Free PMC article.

2

Assessing the quality of the first batch of evidence-based clinical practice guidelines in traditional Chinese medicine.

Yu WY, Xu JL, Shi NN, Wang LY, Han XJ, Wang YY, Lv AP. Yu WY, et al. J Tradit Chin Med. 2011 Dec;31(4):376-81. doi: 10.1016/s0254-6272(12)60021-1. J Tradit Chin Med. 2011. PMID: 22462248

3

[Clinical application evaluation of Guidelines for the Diagnosis and Treatment of Common Diseases of Pediatrics in Traditional Chinese Medicine].

Liu MY, Yang W, Wang LY, Zhao XY, Wang YX, Liu YQ, Han XJ, Lv AP. Liu MY, et al. Zhongguo Zhong Yao Za Zhi. 2017 Sep;42(17):3238-3242. doi: 10.19540/j.cnki.cjcmm.20170623.001. Zhongguo Zhong Yao Za Zhi. 2017. PMID: 29192428 Chinese.

4

[Methodological thoughts on clinical efficacy evaluation with multiple clinical trials].

Lv AP, Wang YY. Lv AP, et al. Zhongguo Zhong Yao Za Zhi. 2006 Aug;31(16):1384-5. Zhongguo Zhong Yao Za Zhi. 2006. PMID: 17061564 Chinese.

5

Duration of viral shedding of influenza A (H1N1) virus infection treated with oseltamivir and/or traditional Chinese medicine in China: a retrospective analysis.

Wang YG, Jiang M, Wang RB, Zha QL, Zhang SJ, Zhou GQ, Li XW, Wang YY, Lv AP. Wang YG, et al. J Tradit Chin Med. 2012 Jun;32(2):148-55. doi: 10.1016/s0254-6272(13)60004-7. J Tradit Chin Med. 2012. PMID: 22876436 Free article.

6

Interactions between phytochemicals from traditional Chinese medicines and human cytochrome P450 enzymes.

Wu JJ, Ai CZ, Liu Y, Zhang YY, Jiang M, Fan XR, Lv AP, Yang L. Wu JJ, et al. Curr Drug Metab. 2012 Jun 1;13(5):599-614. doi: 10.2174/1389200211209050599. Curr Drug Metab. 2012. PMID: 22475333 Review.

7

[Zheng Classification in Chinese Medicine: from Its Integration with Disease Diagnosis to Clinical Effectiveness Assessment and Combinational New Drug Discovery].

Lv AP. Lv AP. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2015 Aug;35(8):942-5. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2015. PMID: 26485907 Chinese.

8

QiShenYiQi Pills, a compound in Chinese medicine, protects against pressure overload-induced cardiac hypertrophy through a multi-component and multi-target mode.

Chen YY, Li Q, Pan CS, Yan L, Fan JY, He K, Sun K, Liu YY, Chen QF, Bai Y, Wang CS, He B, Lv AP, Han JY. Chen YY, et al. Sci Rep. 2015 Jul 2;5:11802. doi: 10.1038/srep11802. Sci Rep. 2015. PMID: 26136154 Free PMC article.

9

Protective effects of Huang-Lian-Jie-Du-Tang and its component group on collagen-induced arthritis in rats.

Hu Y, Hu Z, Wang S, Dong X, Xiao C, Jiang M, Lv A, Zhang W, Liu R. Hu Y, et al. Among authors: lv a. J Ethnopharmacol. 2013 Dec 12;150(3):1137-44. doi: 10.1016/j.jep.2013.10.038. Epub 2013 Nov 7. J Ethnopharmacol. 2013. PMID: 24212076

10

[Being Exposed to Specific Syndromes of Chinese Medicine and Being Compatible with Components of Chinese Herbs Are Important Ways to Control Toxicity of Toxic Chinese Herbs].

Tan Y, Li J, Xiao C, Lv C, Lv AP. Tan Y, et al. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2017 Jan;37(1):115-118. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2017. PMID: 30695436 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

353 results

Search Page

Filters